Evolus Inc. (EOLS)
Evolus Statistics
Share Statistics
Evolus has 63.32M shares outstanding. The number of shares has increased by 2.97% in one year.
Shares Outstanding | 63.32M |
Shares Change (YoY) | 2.97% |
Shares Change (QoQ) | 0.36% |
Owned by Institutions (%) | 79.65% |
Shares Floating | 55.95M |
Failed to Deliver (FTD) Shares | 230 |
FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 5.93M, so 9.37% of the outstanding shares have been sold short.
Short Interest | 5.93M |
Short % of Shares Out | 9.37% |
Short % of Float | 10.84% |
Short Ratio (days to cover) | 8.5 |
Valuation Ratios
The PE ratio is -9.72 and the forward PE ratio is 656.67. Evolus's PEG ratio is 0.52.
PE Ratio | -9.72 |
Forward PE | 656.67 |
PS Ratio | 2.97 |
Forward PS | 1.3 |
PB Ratio | -28.97 |
P/FCF Ratio | -16.82 |
PEG Ratio | 0.52 |
Enterprise Valuation
Evolus Inc. has an Enterprise Value (EV) of 663.06M.
EV / Earnings | -10.75 |
EV / Sales | 3.28 |
EV / EBITDA | -15.86 |
EV / EBIT | -13.47 |
EV / FCF | -18.61 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of -6.12.
Current Ratio | 2.33 |
Quick Ratio | 2.1 |
Debt / Equity | -6.12 |
Total Debt / Capitalization | 119.54 |
Cash Flow / Debt | -0.27 |
Interest Coverage | -3.56 |
Financial Efficiency
Return on equity (ROE) is 2.98% and return on capital (ROIC) is -46.64%.
Return on Equity (ROE) | 2.98% |
Return on Assets (ROA) | -0.33% |
Return on Capital (ROIC) | -46.64% |
Revenue Per Employee | $627,593.17 |
Profits Per Employee | $-191,568.32 |
Employee Count | 322 |
Asset Turnover | 1.07 |
Inventory Turnover | 5.6 |
Taxes
Income Tax | 176K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -2.65% in the last 52 weeks. The beta is 1.28, so Evolus's price volatility has been higher than the market average.
Beta | 1.28 |
52-Week Price Change | -2.65% |
50-Day Moving Average | 12.68 |
200-Day Moving Average | 13.52 |
Relative Strength Index (RSI) | 55.65 |
Average Volume (20 Days) | 729.98K |
Income Statement
In the last 12 months, Evolus had revenue of 202.09M and earned -61.69M in profits. Earnings per share was -1.08.
Revenue | 202.09M |
Gross Profit | 140.53M |
Operating Income | -49.23M |
Net Income | -61.69M |
EBITDA | -41.81M |
EBIT | -49.23M |
Earnings Per Share (EPS) | -1.08 |
Balance Sheet
The company has 62.84M in cash and 126.55M in debt, giving a net cash position of -63.71M.
Cash & Cash Equivalents | 62.84M |
Total Debt | 126.55M |
Net Cash | -63.71M |
Retained Earnings | -558.98M |
Total Assets | 229.61M |
Working Capital | 89.55M |
Cash Flow
In the last 12 months, operating cash flow was -34.01M and capital expenditures -1.63M, giving a free cash flow of -35.63M.
Operating Cash Flow | -34.01M |
Capital Expenditures | -1.63M |
Free Cash Flow | -35.63M |
FCF Per Share | -0.63 |
Margins
Gross margin is 69.54%, with operating and profit margins of -24.36% and -30.52%.
Gross Margin | 69.54% |
Operating Margin | -24.36% |
Pretax Margin | -30.44% |
Profit Margin | -30.52% |
EBITDA Margin | -20.69% |
EBIT Margin | -24.36% |
FCF Margin | -17.63% |
Dividends & Yields
EOLS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -7.53% |
FCF Yield | -3.92% |
Analyst Forecast
The average price target for EOLS is $23, which is 60.3% higher than the current price. The consensus rating is "Buy".
Price Target | $23 |
Price Target Difference | 60.3% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Scores
Altman Z-Score | -0.36 |
Piotroski F-Score | 5 |